COVID-19 Impact on Global Oral Antidiabetic Agents Market Size, Status and Forecast 2020-2026

August 2020 | 96 pages | ID: C4827A815C82EN
QYResearch

Abstracts

This report focuses on the global Oral Antidiabetic Agents status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Antidiabetic Agents development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Novo Nordisk
• Eli Lilly
• Sanofi
• Roche
• Teva
• AstraZeneca
• Wockhardt UK
• Merck
• Pfizer
• Cipla

Market segment by Type, the product can be split into

• Sulfonylureas
• Meglitinides
• Biguanides
• Thiazolidinediones
• Alpha-glucosidase Inhibitors

Market segment by Application, split into

• Home Use
• Medical Institutions
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Oral Antidiabetic Agents status, future forecast, growth opportunity, key market and key players.
• To present the Oral Antidiabetic Agents development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Oral Antidiabetic Agents are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Antidiabetic Agents Revenue
1.4 Market Analysis by Type
  1.4.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Sulfonylureas
  1.4.3 Meglitinides
  1.4.4 Biguanides
  1.4.5 Thiazolidinediones
  1.4.6 Alpha-glucosidase Inhibitors
1.5 Market by Application
  1.5.1 Global Oral Antidiabetic Agents Market Share by Application: 2020 VS 2026
  1.5.2 Home Use
  1.5.3 Medical Institutions
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Oral Antidiabetic Agents Industry Impact
  1.6.1 How the Covid-19 is Affecting the Oral Antidiabetic Agents Industry
    1.6.1.1 Oral Antidiabetic Agents Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Oral Antidiabetic Agents Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Oral Antidiabetic Agents Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Oral Antidiabetic Agents Market Perspective (2015-2026)
2.2 Oral Antidiabetic Agents Growth Trends by Regions
  2.2.1 Oral Antidiabetic Agents Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Oral Antidiabetic Agents Historic Market Share by Regions (2015-2020)
  2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Oral Antidiabetic Agents Market Growth Strategy
  2.3.6 Primary Interviews with Key Oral Antidiabetic Agents Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Oral Antidiabetic Agents Players by Market Size
  3.1.1 Global Top Oral Antidiabetic Agents Players by Revenue (2015-2020)
  3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2015-2020)
  3.1.3 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oral Antidiabetic Agents Market Concentration Ratio
  3.2.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2019
3.3 Oral Antidiabetic Agents Key Players Head office and Area Served
3.4 Key Players Oral Antidiabetic Agents Product Solution and Service
3.5 Date of Enter into Oral Antidiabetic Agents Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2015-2020)
4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2021-2026)

5 ORAL ANTIDIABETIC AGENTS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Oral Antidiabetic Agents Market Size by Application (2015-2020)
5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Oral Antidiabetic Agents Market Size (2015-2020)
6.2 Oral Antidiabetic Agents Key Players in North America (2019-2020)
6.3 North America Oral Antidiabetic Agents Market Size by Type (2015-2020)
6.4 North America Oral Antidiabetic Agents Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Oral Antidiabetic Agents Market Size (2015-2020)
7.2 Oral Antidiabetic Agents Key Players in Europe (2019-2020)
7.3 Europe Oral Antidiabetic Agents Market Size by Type (2015-2020)
7.4 Europe Oral Antidiabetic Agents Market Size by Application (2015-2020)

8 CHINA

8.1 China Oral Antidiabetic Agents Market Size (2015-2020)
8.2 Oral Antidiabetic Agents Key Players in China (2019-2020)
8.3 China Oral Antidiabetic Agents Market Size by Type (2015-2020)
8.4 China Oral Antidiabetic Agents Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Oral Antidiabetic Agents Market Size (2015-2020)
9.2 Oral Antidiabetic Agents Key Players in Japan (2019-2020)
9.3 Japan Oral Antidiabetic Agents Market Size by Type (2015-2020)
9.4 Japan Oral Antidiabetic Agents Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Oral Antidiabetic Agents Market Size (2015-2020)
10.2 Oral Antidiabetic Agents Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Oral Antidiabetic Agents Market Size by Type (2015-2020)
10.4 Southeast Asia Oral Antidiabetic Agents Market Size by Application (2015-2020)

11 INDIA

11.1 India Oral Antidiabetic Agents Market Size (2015-2020)
11.2 Oral Antidiabetic Agents Key Players in India (2019-2020)
11.3 India Oral Antidiabetic Agents Market Size by Type (2015-2020)
11.4 India Oral Antidiabetic Agents Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Oral Antidiabetic Agents Market Size (2015-2020)
12.2 Oral Antidiabetic Agents Key Players in Central & South America (2019-2020)
12.3 Central & South America Oral Antidiabetic Agents Market Size by Type (2015-2020)
12.4 Central & South America Oral Antidiabetic Agents Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Novo Nordisk
  13.1.1 Novo Nordisk Company Details
  13.1.2 Novo Nordisk Business Overview and Its Total Revenue
  13.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction
  13.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2015-2020))
  13.1.5 Novo Nordisk Recent Development
13.2 Eli Lilly
  13.2.1 Eli Lilly Company Details
  13.2.2 Eli Lilly Business Overview and Its Total Revenue
  13.2.3 Eli Lilly Oral Antidiabetic Agents Introduction
  13.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.2.5 Eli Lilly Recent Development
13.3 Sanofi
  13.3.1 Sanofi Company Details
  13.3.2 Sanofi Business Overview and Its Total Revenue
  13.3.3 Sanofi Oral Antidiabetic Agents Introduction
  13.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.3.5 Sanofi Recent Development
13.4 Roche
  13.4.1 Roche Company Details
  13.4.2 Roche Business Overview and Its Total Revenue
  13.4.3 Roche Oral Antidiabetic Agents Introduction
  13.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.4.5 Roche Recent Development
13.5 Teva
  13.5.1 Teva Company Details
  13.5.2 Teva Business Overview and Its Total Revenue
  13.5.3 Teva Oral Antidiabetic Agents Introduction
  13.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.5.5 Teva Recent Development
13.6 AstraZeneca
  13.6.1 AstraZeneca Company Details
  13.6.2 AstraZeneca Business Overview and Its Total Revenue
  13.6.3 AstraZeneca Oral Antidiabetic Agents Introduction
  13.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.6.5 AstraZeneca Recent Development
13.7 Wockhardt UK
  13.7.1 Wockhardt UK Company Details
  13.7.2 Wockhardt UK Business Overview and Its Total Revenue
  13.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction
  13.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.7.5 Wockhardt UK Recent Development
13.8 Merck
  13.8.1 Merck Company Details
  13.8.2 Merck Business Overview and Its Total Revenue
  13.8.3 Merck Oral Antidiabetic Agents Introduction
  13.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.8.5 Merck Recent Development
13.9 Pfizer
  13.9.1 Pfizer Company Details
  13.9.2 Pfizer Business Overview and Its Total Revenue
  13.9.3 Pfizer Oral Antidiabetic Agents Introduction
  13.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.9.5 Pfizer Recent Development
13.10 Cipla
  13.10.1 Cipla Company Details
  13.10.2 Cipla Business Overview and Its Total Revenue
  13.10.3 Cipla Oral Antidiabetic Agents Introduction
  13.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2015-2020)
  13.10.5 Cipla Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Oral Antidiabetic Agents Key Market Segments
Table 2. Key Players Covered: Ranking by Oral Antidiabetic Agents Revenue
Table 3. Ranking of Global Top Oral Antidiabetic Agents Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sulfonylureas
Table 6. Key Players of Meglitinides
Table 7. Key Players of Biguanides
Table 8. Key Players of Thiazolidinediones
Table 9. Key Players of Alpha-glucosidase Inhibitors
Table 10. COVID-19 Impact Global Market: (Four Oral Antidiabetic Agents Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Oral Antidiabetic Agents Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Oral Antidiabetic Agents Players to Combat Covid-19 Impact
Table 15. Global Oral Antidiabetic Agents Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Oral Antidiabetic Agents Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Oral Antidiabetic Agents Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Oral Antidiabetic Agents Market Share by Regions (2015-2020)
Table 19. Global Oral Antidiabetic Agents Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Oral Antidiabetic Agents Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Oral Antidiabetic Agents Market Growth Strategy
Table 25. Main Points Interviewed from Key Oral Antidiabetic Agents Players
Table 26. Global Oral Antidiabetic Agents Revenue by Players (2015-2020) (Million US$)
Table 27. Global Oral Antidiabetic Agents Market Share by Players (2015-2020)
Table 28. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Antidiabetic Agents as of 2019)
Table 29. Global Oral Antidiabetic Agents by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Oral Antidiabetic Agents Product Solution and Service
Table 32. Date of Enter into Oral Antidiabetic Agents Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 35. Global Oral Antidiabetic Agents Market Size Share by Type (2015-2020)
Table 36. Global Oral Antidiabetic Agents Revenue Market Share by Type (2021-2026)
Table 37. Global Oral Antidiabetic Agents Market Size Share by Application (2015-2020)
Table 38. Global Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 39. Global Oral Antidiabetic Agents Market Size Share by Application (2021-2026)
Table 40. North America Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 42. North America Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 43. North America Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 44. North America Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 45. North America Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 46. Europe Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 48. Europe Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 50. Europe Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 52. China Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 53. China Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 54. China Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 55. China Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 56. China Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 57. China Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 58. Japan Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 60. Japan Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 62. Japan Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 66. Southeast Asia Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 68. Southeast Asia Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 70. India Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 71. India Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 72. India Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 73. India Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 74. India Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 75. India Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Oral Antidiabetic Agents Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Oral Antidiabetic Agents Market Share (2019-2020)
Table 78. Central & South America Oral Antidiabetic Agents Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Oral Antidiabetic Agents Market Share by Type (2015-2020)
Table 80. Central & South America Oral Antidiabetic Agents Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Oral Antidiabetic Agents Market Share by Application (2015-2020)
Table 82. Novo Nordisk Company Details
Table 83. Novo Nordisk Business Overview
Table 84. Novo Nordisk Product
Table 85. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 86. Novo Nordisk Recent Development
Table 87. Eli Lilly Company Details
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Product
Table 90. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 91. Eli Lilly Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Product
Table 95. Sanofi Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 96. Sanofi Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Product
Table 100. Roche Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 101. Roche Recent Development
Table 102. Teva Company Details
Table 103. Teva Business Overview
Table 104. Teva Product
Table 105. Teva Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 106. Teva Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Product
Table 110. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 111. AstraZeneca Recent Development
Table 112. Wockhardt UK Company Details
Table 113. Wockhardt UK Business Overview
Table 114. Wockhardt UK Product
Table 115. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 116. Wockhardt UK Recent Development
Table 117. Merck Business Overview
Table 118. Merck Product
Table 119. Merck Company Details
Table 120. Merck Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 121. Merck Recent Development
Table 122. Pfizer Company Details
Table 123. Pfizer Business Overview
Table 124. Pfizer Product
Table 125. Pfizer Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 126. Pfizer Recent Development
Table 127. Cipla Company Details
Table 128. Cipla Business Overview
Table 129. Cipla Product
Table 130. Cipla Revenue in Oral Antidiabetic Agents Business (2015-2020) (Million US$)
Table 131. Cipla Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Oral Antidiabetic Agents Market Share by Type: 2020 VS 2026
Figure 2. Sulfonylureas Features
Figure 3. Meglitinides Features
Figure 4. Biguanides Features
Figure 5. Thiazolidinediones Features
Figure 6. Alpha-glucosidase Inhibitors Features
Figure 7. Global Oral Antidiabetic Agents Market Share by Application: 2020 VS 2026
Figure 8. Home Use Case Studies
Figure 9. Medical Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Antidiabetic Agents Report Years Considered
Figure 12. Global Oral Antidiabetic Agents Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Oral Antidiabetic Agents Market Share by Regions: 2020 VS 2026
Figure 14. Global Oral Antidiabetic Agents Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Oral Antidiabetic Agents Market Share by Players in 2019
Figure 17. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Antidiabetic Agents as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2019
Figure 19. North America Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Oral Antidiabetic Agents Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 28. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 30. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 32. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 34. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 36. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 38. Wockhardt UK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 40. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 42. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 44. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed